ZA916425B - Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes,3-aminochromanes,and 3-aminothiochromanes - Google Patents

Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes,3-aminochromanes,and 3-aminothiochromanes

Info

Publication number: ZA916425B
Authority: ZA; South Africa
Prior art keywords: alkyl; substituted; hydrogen; aryl; cycloalkyl
Prior art date: 1990-08-15

Application number

ZA916425A

Other languages

English (en)

Inventor

John M Schaus

M Schaus John

Craig S Hoechstetter

S Hoechstetter Craig

Diane Huser

Huser Diane

Charles J Paget

J Paget Charles

Robert D Titus

D Titus Robert

Original Assignee

Lilly Co Eli

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-08-15

Filing date

1991-08-14

Publication date

1993-04-28

1991-08-14 Application filed by Lilly Co Eli filed Critical Lilly Co Eli

1993-04-28 Publication of ZA916425B publication Critical patent/ZA916425B/xx

Links

HMJPRXLPAGOYFX-UHFFFAOYSA-N 3,4-dihydro-2h-thiochromen-3-amine Chemical class C1=CC=C2CC(N)CSC2=C1 HMJPRXLPAGOYFX-UHFFFAOYSA-N 0.000 title abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 8
229910052739 hydrogen Inorganic materials 0.000 abstract 5
239000001257 hydrogen Substances 0.000 abstract 5
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 5
125000003118 aryl group Chemical group 0.000 abstract 3
125000000753 cycloalkyl group Chemical group 0.000 abstract 3
125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 2
125000003342 alkenyl group Chemical group 0.000 abstract 2
125000004186 cyclopropylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C1([H])[H] 0.000 abstract 2
125000003107 substituted aryl group Chemical group 0.000 abstract 2
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
125000006656 (C2-C4) alkenyl group Chemical group 0.000 abstract 1
LCGFVWKNXLRFIF-UHFFFAOYSA-N 1,2,3,4-tetrahydronaphthalen-2-amine Chemical class C1=CC=C2CC(N)CCC2=C1 LCGFVWKNXLRFIF-UHFFFAOYSA-N 0.000 abstract 1
SVWDNDQOXZHBRM-UHFFFAOYSA-N 3,4-dihydro-2h-chromen-3-amine Chemical class C1=CC=C2CC(N)COC2=C1 SVWDNDQOXZHBRM-UHFFFAOYSA-N 0.000 abstract 1
101710138638 5-hydroxytryptamine receptor 1A Proteins 0.000 abstract 1
102000017911 HTR1A Human genes 0.000 abstract 1
239000002253 acid Substances 0.000 abstract 1
239000000556 agonist Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000002496 methyl group Chemical class [H]C([H])([H])* 0.000 abstract 1
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
150000003457 sulfones Chemical class 0.000 abstract 1
150000003462 sulfoxides Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
- C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C225/00—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones
- C07C225/20—Compounds containing amino groups and doubly—bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly—bound oxygen atoms not being part of a —CHO group, e.g. amino ketones having amino groups bound to carbon atoms of rings other than six-membered aromatic rings of the carbon skeleton
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Gynecology & Obstetrics (AREA)
Hospice & Palliative Care (AREA)
Pregnancy & Childbirth (AREA)
Addiction (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
Lubricants (AREA)
Indole Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Detergent Compositions (AREA)
Pyrane Compounds (AREA)
Peptides Or Proteins (AREA)
Plural Heterocyclic Compounds (AREA)
Cosmetics (AREA)
Saccharide Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

ZA916425A 1990-08-15 1991-08-14 Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes,3-aminochromanes,and 3-aminothiochromanes ZA916425B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US56798590A	1990-08-15	1990-08-15

Publications (1)

Publication Number	Publication Date
ZA916425B true ZA916425B (en)	1993-04-28

Family

ID=24269428

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA916425A ZA916425B (en)	1990-08-15	1991-08-14	Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes,3-aminochromanes,and 3-aminothiochromanes

Country Status (25)

Country	Link
US (5)	US5286753A (de)
EP (1)	EP0471515B1 (de)
JP (1)	JPH04244050A (de)
KR (1)	KR920004331A (de)
CN (1)	CN1039967C (de)
AT (1)	ATE149480T1 (de)
AU (1)	AU652569B2 (de)
CA (1)	CA2048846A1 (de)
CZ (1)	CZ281137B6 (de)
DE (1)	DE69124868T2 (de)
DK (1)	DK0471515T3 (de)
ES (1)	ES2100211T3 (de)
FI (1)	FI913833L (de)
GR (1)	GR3023409T3 (de)
HU (1)	HU218668B (de)
IE (1)	IE912880A1 (de)
IL (1)	IL99175A (de)
MX (1)	MX9100675A (de)
MY (1)	MY110619A (de)
NO (1)	NO176094C (de)
NZ (1)	NZ239371A (de)
PT (1)	PT98641B (de)
RU (1)	RU2060245C1 (de)
YU (1)	YU48695B (de)
ZA (1)	ZA916425B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK0389425T3 (da) *	1989-03-22	1995-05-22	Ciba Geigy Ag	Benzothiopyranylaminer
US5420151A (en) *	1989-12-22	1995-05-30	Aktiebolaget Astra	Chroman derivatives
US5616610A (en) *	1989-12-22	1997-04-01	Astra Aktiebolag	(R)-5-carbamoyl-8-fluoro-3-N,N-disubstituted-amino-3,4-dihydro-2H-1-benzopyrans
US5340838A (en) *	1990-05-04	1994-08-23	Eli Lilly And Company	Method of inhibiting gastric acid secretion with 2-phenylcyclopropylamines
DK0471515T3 (da) *	1990-08-15	1997-07-21	Lilly Co Eli	Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
NZ241495A (en) *	1991-02-08	1994-10-26	Lilly Co Eli	2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivative, preparation and pharmaceutical compositions thereof
AU654573B2 (en) *	1991-08-21	1994-11-10	Eli Lilly And Company	Benzo(f)quinolinones
FR2691149B1 (fr) *	1992-05-18	1994-07-08	Adir	Nouveaux composes thiochromaniques, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
WO1994022495A1 (en) *	1993-03-31	1994-10-13	The Trustees Of The University Of Pennsylvania	Dopamine d-3 and serotonin (5-ht1a) receptor ligands and imaging agents
US5837702A (en) *	1993-10-07	1998-11-17	Bristol-Myers Squibb Co.	4-arylamino-benzopyran and related compounds
FR2717175B1 (fr) *	1994-03-11	1996-06-14	Adir	Nouveaux composés alkylaminoindanes, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
US5482942A (en) *	1994-06-28	1996-01-09	American Home Products Corporation	(3,4-dioxocyclobuten-1-yl)chromene, indene, and dihydronaphthalenone derivatives as smooth muscle relaxants
US5629429A (en) *	1995-06-07	1997-05-13	Bristol-Myers Squibb Company	Process for preparing 4-arylamino-benzopyran and related compounds
US5612370A (en) *	1995-06-07	1997-03-18	Bristol-Myers Squibb Company	Phenylglycine and phenylalaninen amido benzopyran derivatives
US5869478A (en) *	1995-06-07	1999-02-09	Bristol-Myers Squibb Company	Sulfonamido substituted benzopyran derivatives
US5612323A (en) *	1995-06-07	1997-03-18	Bristol-Myers Squibb Company	Phosphinic ester substituted benzopyran derivatives
CN1817906B (zh) *	1996-09-26	2011-08-10	中外制药株式会社	抗人副甲状腺激素相关蛋白的抗体
US6355674B1 (en)	1997-04-30	2002-03-12	Eli Lilly And Company	Aminotetralins as 5-HT1D α Agonists
EP1052982A4 (de) *	1997-04-30	2004-10-06	Lilly Co Eli	AMINOTETRALINE ALS 5HT1D-alpha AGONISTEN
DE19742509A1 (de) *	1997-09-26	1999-04-01	Hoechst Marion Roussel De Gmbh	Sulfonamid-substituierte Chromane, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen
US5962488A (en)	1998-04-08	1999-10-05	Roberts Laboratories, Inc.	Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives
FR2792529B1 (fr) *	1999-04-26	2001-09-28	Sod Conseils Rech Applic	Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
US7060847B2 (en) *	2003-07-18	2006-06-13	Roche Diagnostics Operations, Inc.	Ecstasy-class derivatives, immunogens, and antibodies and their use in detecting ecstasy-class drugs

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3637740A (en) *	1969-04-21	1972-01-25	Pfizer	Aminobenzocycloalkane compounds
US3930022A (en) *	1972-07-03	1975-12-30	Squibb & Sons Inc	Certain tetrahydronaphthalenes used in the treatment of cardiac arrhythmia
DE3062971D1 (en) *	1979-09-14	1983-06-09	Sandoz Ag	Derivatives of tetraline, their preparation and medicaments containing these compounds
SE8004002L (sv) *	1980-05-29	1981-11-30	Arvidsson Folke Lars Erik	Terapeutiskt anvendbara tetralinderivat
IL65501A (en) *	1981-05-08	1986-04-29	Astra Laekemedel Ab	1-alkyl-2-aminotetralin derivatives,process for their preparation and pharmaceutical compositions containing them
JPS5970653A (ja) *	1982-10-15	1984-04-21	Takeda Chem Ind Ltd	眼圧低下剤
US4520030A (en) *	1983-12-12	1985-05-28	Synthelabo	Anti-ulcer agents
US4975461A (en) *	1986-06-19	1990-12-04	E. R. Squibb & Sons, Inc.	P-aminophenols, derivatives thereof and method of use
US4801605A (en) *	1986-08-29	1989-01-31	Ciba-Geigy Corporation	3-amino-dihydro-[1]-benzopyrans and benzothiopyrans
SE8605504D0 (sv) *	1986-12-19	1986-12-19	Astra Laekemedel Ab	Novel chroman derivatives
DE3719924A1 (de) *	1986-12-22	1988-06-30	Bayer Ag	8-substituierte 2-aminotetraline
CA1331191C (en) *	1988-03-25	1994-08-02	Bengt Ronny Andersson	Therapeutically useful tetralin derivatives
CA1335591C (en) *	1988-05-23	1995-05-16	James Arthur Nixon	Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes
US4873265A (en) *	1988-07-14	1989-10-10	Thomes Pharmacal Co., Inc.	Anti-infective methods and compositions
IL114715A (en) *	1989-02-27	1997-01-10	Lilly Co Eli	Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes
CA1335106C (en) *	1989-02-27	1995-04-04	John Mehnert Schaus	Ring-substituted 2-amino-1,2,3,4-tetra-hydronaphthalenes
US5306830A (en) *	1989-04-27	1994-04-26	The Upjohn Company	Substituted 3-amino chromans
DE69005625T2 (de) *	1989-04-27	1994-05-11	Upjohn Co	Substituierte 3-amino-chromane.
BE1004067A6 (fr) *	1989-05-23	1992-09-15	Cockerill Sambre Sa	Dispositif d'arret d'urgence pour installation industrielle.
SE8901889D0 (sv) *	1989-05-26	1989-05-26	Astra Ab	Novel 8-substituted-2-aminotetralines
DE69032725T2 (de) *	1989-05-31	1999-04-08	Pharmacia & Upjohn Co., Kalamazoo, Mich.	ZNS-wirksame 8-Heterocyclyl-2-aminotetralin Derivate
SE8904361D0 (sv) *	1989-12-22	1989-12-22	Astra Ab	New chroman and thiochroman derivatives
US5229410A (en) *	1990-08-15	1993-07-20	Eli Lilly And Company	6-substituted-hexahydrobenz[cd]indoles
DK0471515T3 (da) *	1990-08-15	1997-07-21	Lilly Co Eli	Ringsubstituerede 2-amino-1,2,3,4-tetrahydronphtalener, 3-aminochromaner og 3-aminothiochromaner
NZ241495A (en) *	1991-02-08	1994-10-26	Lilly Co Eli	2-amino-1,2,3,4-tetrahydronaphthalene and 3-aminochromane derivative, preparation and pharmaceutical compositions thereof
FR2689509B1 (fr) *	1992-04-01	1994-06-03	Adir	Nouveaux derives spiraniques du 3-amino chromane, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.

1991
- 1991-08-09 DK DK91307328.4T patent/DK0471515T3/da active
- 1991-08-09 AT AT91307328T patent/ATE149480T1/de not_active IP Right Cessation
- 1991-08-09 EP EP91307328A patent/EP0471515B1/de not_active Expired - Lifetime
- 1991-08-09 DE DE69124868T patent/DE69124868T2/de not_active Expired - Fee Related
- 1991-08-09 CA CA002048846A patent/CA2048846A1/en not_active Abandoned
- 1991-08-09 ES ES91307328T patent/ES2100211T3/es not_active Expired - Lifetime
- 1991-08-12 PT PT98641A patent/PT98641B/pt not_active IP Right Cessation
- 1991-08-12 CZ CS912493A patent/CZ281137B6/cs not_active IP Right Cessation
- 1991-08-13 IL IL99175A patent/IL99175A/en not_active IP Right Cessation
- 1991-08-13 NZ NZ239371A patent/NZ239371A/xx unknown
- 1991-08-13 AU AU82403/91A patent/AU652569B2/en not_active Ceased
- 1991-08-13 FI FI913833A patent/FI913833L/fi not_active Application Discontinuation
- 1991-08-14 ZA ZA916425A patent/ZA916425B/xx unknown
- 1991-08-14 IE IE288091A patent/IE912880A1/en unknown
- 1991-08-14 JP JP3204223A patent/JPH04244050A/ja active Pending
- 1991-08-14 KR KR1019910014065A patent/KR920004331A/ko not_active Withdrawn
- 1991-08-14 NO NO913175A patent/NO176094C/no not_active IP Right Cessation
- 1991-08-14 MY MYPI91001472A patent/MY110619A/en unknown
- 1991-08-14 RU SU915001360A patent/RU2060245C1/ru not_active IP Right Cessation
- 1991-08-14 YU YU140291A patent/YU48695B/sh unknown
- 1991-08-14 HU HU708/91A patent/HU218668B/hu not_active IP Right Cessation
- 1991-08-14 CN CN91109092A patent/CN1039967C/zh not_active Expired - Fee Related
- 1991-08-15 MX MX9100675A patent/MX9100675A/es not_active IP Right Cessation
1993
- 1993-04-16 US US08/048,553 patent/US5286753A/en not_active Expired - Fee Related
- 1993-12-16 US US08/168,794 patent/US5426229A/en not_active Expired - Fee Related
1995
- 1995-03-14 US US08/404,391 patent/US5466709A/en not_active Expired - Fee Related
- 1995-03-14 US US08/404,390 patent/US5470977A/en not_active Expired - Fee Related
- 1995-03-14 US US08/403,598 patent/US5552444A/en not_active Expired - Fee Related
1997
- 1997-05-12 GR GR970401064T patent/GR3023409T3/el unknown

Also Published As

Publication number	Publication date
HUT61965A (en)	1993-03-29
JPH04244050A (ja)	1992-09-01
DK0471515T3 (da)	1997-07-21
YU48695B (sh)	1999-07-28
ES2100211T3 (es)	1997-06-16
US5470977A (en)	1995-11-28
IE912880A1 (en)	1992-02-26
HU218668B (hu)	2000-10-28
CN1039967C (zh)	1998-09-30
MY110619A (en)	1998-09-30
IL99175A (en)	1998-06-15
CA2048846A1 (en)	1992-02-16
CS249391A3 (en)	1992-03-18
NO176094B (no)	1994-10-24
CN1059903A (zh)	1992-04-01
ATE149480T1 (de)	1997-03-15
GR3023409T3 (en)	1997-08-29
FI913833A7 (fi)	1992-02-16
YU140291A (sh)	1994-01-20
MX9100675A (es)	1992-04-01
US5286753A (en)	1994-02-15
PT98641B (pt)	1999-01-29
KR920004331A (ko)	1992-03-27
EP0471515B1 (de)	1997-03-05
AU652569B2 (en)	1994-09-01
DE69124868T2 (de)	1997-07-10
NZ239371A (en)	1993-01-27
US5426229A (en)	1995-06-20
NO176094C (no)	1995-02-01
HU912708D0 (en)	1992-01-28
DE69124868D1 (de)	1997-04-10
FI913833A0 (fi)	1991-08-13
US5552444A (en)	1996-09-03
US5466709A (en)	1995-11-14
NO913175D0 (no)	1991-08-14
EP0471515A1 (de)	1992-02-19
NO913175L (no)	1992-02-17
AU8240391A (en)	1992-02-20
IL99175A0 (en)	1992-07-15
CZ281137B6 (cs)	1996-06-12
FI913833L (fi)	1992-02-16
RU2060245C1 (ru)	1996-05-20
PT98641A (pt)	1992-06-30

Publication	Publication Date	Title
ZA916425B (en)	1993-04-28	Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes,3-aminochromanes,and 3-aminothiochromanes
HUT44044A (en)	1988-01-28	Process for preparing place-specific alkylating agents
KR930703319A (ko)	1993-11-29	키산틴 유도체
MY116454A (en)	2004-02-28	Ring-substituted 2-amino-1, 2,3,4-tetra- hydronaphthalenes and 3-aminochromanes.
ZA901277B (en)	1991-10-30	Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes and 3-aminochromanes
MX11866A (es)	1993-12-01	Nuevas cicloalquilamidas y procedimiento para su preparacion.
SE8800863L (sv)	1989-09-12	3-(2-haloalkyl)-1,4-oxatiiner och 2-(2-haloalkyl)1,4-ditiiner och bahandling av leukemi och tumoerer daermed
IL107389A (en)	1997-07-13	N-substituted carbonyloxyalkyl- pyrroles and insecticidal, acaricidal and molluscicidal compositions containing them
PT82693A (en)	1986-07-01	Process for the preparation of benzaldoxime carbamate derivatives having a fungicidal effect
NZ221004A (en)	1989-07-27	2,6-piperazinediones and pharamceutical compositions
ES8505653A1 (es)	1985-06-16	Procedimiento para preparar un n-alquil-(3 o 4)piperidinil benzoato
EP0877026A4 (de)	1999-04-07	Substituierte 6-r-1,3,4-thiadiazin-2-amine, ihre anwendung als anesthetika, kardiovaskuläre und hypometabolische mittel und eine diese verbindungen enthaltende pharmazeutische zusammensetzung
SE7902264L (sv)	1980-09-15	N,n'-bis(fenylkarbamoylmetyl)amidiner och sett for framstellning derav